TC BioPharm News

TC BioPharm | 8-K: Current report

Apr 4 20:45

TC BioPharm | 10-K: Annual report

Apr 2 05:16

TC BioPharm | 8-K: Current report

Mar 19 20:01

TC BioPharm | 8-K: Current report

Mar 18 20:04

TC BioPharm | 8-K: Current report

Mar 12 19:32

TC BioPharm | 8-K: Current report

Mar 6 19:33

TC BioPharm | DEF 14A: Definitive information statements

Feb 20 19:08

TC BioPharm | 8-K: Current report

Feb 15 04:08

TC BioPharm | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)

Feb 15 03:39

TC BioPharm | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Feb 10 04:30

TC BioPharm | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MEDINET Co., Ltd.(0.0%)

Jan 29 22:18

TC BioPharm | 8-K: Current report

Jan 4 13:00

TC BioPharm | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 22, 2023 06:14

TC BioPharm | 424B4: Prospectus

Dec 21, 2023 07:42

TC BioPharm | EFFECT: Others

Dec 19, 2023 13:15

TC BioPharm | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Dec 15, 2023 06:20

TC BioPharm | CORRESP: CORRESP

Dec 14, 2023 13:00

TC BioPharm | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 13, 2023 22:05

TC BioPharm | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Dec 13, 2023 10:34

TC BioPharm | 424B3: Prospectus

Nov 9, 2023 05:05